Related Funds
Funds with similar focus
Fund Name | Location |
Buckley Ventures | California, San Francisco, United States |
CP Ventures | Australia, New South Wales, Sydney |
Dreadnought Capital | Connecticut, Stamford, United States |
JRG Capital Partners | Chicago, Illinois, United States |
ReDefine Capital Partners | Colorado, Denver, United States |
RevvX Hardware / IOT Accelerator | Bangalore, India, Karnataka |
Shin-Kong Capital | - |
Talis | France, Ile-de-France, Paris |
The Fund (Attorneys' Title Fund Services) | Florida, Orlando, United States |
TRE Holding | Lucerne, Switzerland, Zug |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Proviva Therapeutics, Inc | $18M | 06 Mar 2024 | - | ||
BioTroy Therapeutics | $15M | 07 Mar 2023 | China, China | ||
Yiyao Technology | $1M | 15 Mar 2022 | Dongcheng District, Beijing, China | ||
SparX Group | $30M | 31 Dec 2021 | - | ||
10 Mar 2021 | Shanghai, China | ||||
Ascentawits | $15M | 11 Feb 2021 | Shenzhen, Guangdong, China | ||
07 Jun 2020 | Vancouver, British Columbia, Canada | ||||
Denovo Biopharma | $46M | 31 Oct 2019 | San Diego, California, United States | ||
04 Apr 2019 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Proviva Therapeutics, Inc | $18M | 06 Mar 2024 | - | ||
BioTroy Therapeutics | $15M | 07 Mar 2023 | China, China | ||
Yiyao Technology | $1M | 15 Mar 2022 | Dongcheng District, Beijing, China | ||
SparX Group | $30M | 31 Dec 2021 | - | ||
10 Mar 2021 | Shanghai, China | ||||
Ascentawits | $15M | 11 Feb 2021 | Shenzhen, Guangdong, China | ||
07 Jun 2020 | Vancouver, British Columbia, Canada | ||||
Denovo Biopharma | $46M | 31 Oct 2019 | San Diego, California, United States | ||
04 Apr 2019 | Futian District, Guangdong Province, China |